|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
randomvirus
|
290 |
86K |
18 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
18
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears Ryoncil IND for Registration Trial in DMD
|
|
randomvirus
|
40 |
16K |
17 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
40
|
16K
|
17
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
randomvirus
|
126 |
38K |
24 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
126
|
38K
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
$4 party
|
|
randomvirus
|
28 |
10K |
7 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
28
|
10K
|
7
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Hits US Milestone - 100 Remplir Units Sold.
|
|
randomvirus
|
34 |
8.3K |
2 |
18/12/25 |
| 18/12/25 |
ASX - By Stock
|
34
|
8.3K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenues Increase 66% in Second Quarter Post Launch
|
|
randomvirus
|
218 |
77K |
12 |
07/10/25 |
| 07/10/25 |
ASX - By Stock
|
218
|
77K
|
12
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
randomvirus
|
21K |
7.7M |
1 |
30/09/25 |
| 30/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Q & A Transcript 29 Aug CC
|
|
randomvirus
|
29 |
8.9K |
21 |
30/08/25 |
| 30/08/25 |
ASX - By Stock
|
29
|
8.9K
|
21
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
randomvirus
|
456 |
217K |
4 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
456
|
217K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
randomvirus
|
456 |
217K |
27 |
18/07/25 |
| 18/07/25 |
ASX - By Stock
|
456
|
217K
|
27
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
randomvirus
|
189 |
83K |
10 |
30/04/25 |
| 30/04/25 |
ASX - By Stock
|
189
|
83K
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
randomvirus
|
189 |
83K |
2 |
30/04/25 |
| 30/04/25 |
ASX - By Stock
|
189
|
83K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
randomvirus
|
21K |
9.0M |
25 |
23/01/25 |
| 23/01/25 |
ASX - By Stock
|
21K
|
9.0M
|
25
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
randomvirus
|
574 |
226K |
6 |
21/09/23 |
| 21/09/23 |
ASX - By Stock
|
574
|
226K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
randomvirus
|
55 |
25K |
8 |
26/05/23 |
| 26/05/23 |
ASX - By Stock
|
55
|
25K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
randomvirus
|
1.0K |
440K |
9 |
08/03/23 |
| 08/03/23 |
ASX - By Stock
|
1.0K
|
440K
|
9
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
randomvirus
|
618 |
266K |
1 |
15/02/23 |
| 15/02/23 |
ASX - By Stock
|
618
|
266K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
randomvirus
|
94 |
34K |
20 |
23/11/22 |
| 23/11/22 |
ASX - By Stock
|
94
|
34K
|
20
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
randomvirus
|
94 |
34K |
22 |
23/11/22 |
| 23/11/22 |
ASX - By Stock
|
94
|
34K
|
22
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
randomvirus
|
321 |
116K |
4 |
09/08/22 |
| 09/08/22 |
ASX - By Stock
|
321
|
116K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
randomvirus
|
373 |
106K |
30 |
12/01/22 |
| 12/01/22 |
ASX - By Stock
|
373
|
106K
|
30
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
randomvirus
|
408 |
143K |
33 |
16/12/21 |
| 16/12/21 |
ASX - By Stock
|
408
|
143K
|
33
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
randomvirus
|
427 |
158K |
1 |
01/07/21 |
| 01/07/21 |
ASX - By Stock
|
427
|
158K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
randomvirus
|
427 |
158K |
9 |
01/07/21 |
| 01/07/21 |
ASX - By Stock
|
427
|
158K
|
9
|
|
|
ASX - By Stock
|
SNT |
Re:
Ann: BTC: Exclusive distribution rights for Bronchitol & Aridol
|
|
randomvirus
|
9 |
3.4K |
3 |
30/06/21 |
| 30/06/21 |
ASX - By Stock
|
9
|
3.4K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
randomvirus
|
422 |
168K |
19 |
21/05/21 |
| 21/05/21 |
ASX - By Stock
|
422
|
168K
|
19
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
randomvirus
|
21K |
9.0M |
3 |
15/03/21 |
| 15/03/21 |
ASX - By Stock
|
21K
|
9.0M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
randomvirus
|
272 |
149K |
16 |
26/02/21 |
| 26/02/21 |
ASX - By Stock
|
272
|
149K
|
16
|
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Financial Results Half Year - Webinar Announcement
|
|
randomvirus
|
17 |
7.5K |
6 |
25/02/21 |
| 25/02/21 |
ASX - By Stock
|
17
|
7.5K
|
6
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
randomvirus
|
10K |
3.4M |
2 |
15/02/21 |
| 15/02/21 |
ASX - By Stock
|
10K
|
3.4M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
349K |
14 |
12/02/21 |
| 12/02/21 |
ASX - By Stock
|
1.1K
|
349K
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
349K |
8 |
12/02/21 |
| 12/02/21 |
ASX - By Stock
|
1.1K
|
349K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
randomvirus
|
21K |
9.0M |
0 |
11/02/21 |
| 11/02/21 |
ASX - By Stock
|
21K
|
9.0M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
349K |
13 |
11/02/21 |
| 11/02/21 |
ASX - By Stock
|
1.1K
|
349K
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
randomvirus
|
49 |
14K |
4 |
11/02/21 |
| 11/02/21 |
ASX - By Stock
|
49
|
14K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
356K |
7 |
12/01/21 |
| 12/01/21 |
ASX - By Stock
|
763
|
356K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
randomvirus
|
136 |
57K |
2 |
12/01/21 |
| 12/01/21 |
ASX - By Stock
|
136
|
57K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
randomvirus
|
136 |
57K |
0 |
11/01/21 |
| 11/01/21 |
ASX - By Stock
|
136
|
57K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
356K |
4 |
11/01/21 |
| 11/01/21 |
ASX - By Stock
|
763
|
356K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
356K |
29 |
11/01/21 |
| 11/01/21 |
ASX - By Stock
|
763
|
356K
|
29
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
100K |
85 |
18/12/20 |
| 18/12/20 |
ASX - By Stock
|
183
|
100K
|
85
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
100K |
1 |
18/12/20 |
| 18/12/20 |
ASX - By Stock
|
183
|
100K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
100K |
3 |
18/12/20 |
| 18/12/20 |
ASX - By Stock
|
183
|
100K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
randomvirus
|
425 |
210K |
14 |
10/12/20 |
| 10/12/20 |
ASX - By Stock
|
425
|
210K
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
randomvirus
|
572 |
279K |
3 |
02/12/20 |
| 02/12/20 |
ASX - By Stock
|
572
|
279K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
randomvirus
|
51 |
22K |
14 |
23/11/20 |
| 23/11/20 |
ASX - By Stock
|
51
|
22K
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
randomvirus
|
811 |
375K |
52 |
20/11/20 |
| 20/11/20 |
ASX - By Stock
|
811
|
375K
|
52
|
|
|
ASX - By Stock
|
MSB |
Re:
Regenerative Medicine and Cell Therapies Virtual Event
|
|
randomvirus
|
129 |
61K |
6 |
19/09/20 |
| 19/09/20 |
ASX - By Stock
|
129
|
61K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
clinicaltrials.gov - MSCs in COVID-19 ARDS
|
|
randomvirus
|
199 |
100K |
26 |
19/09/20 |
| 19/09/20 |
ASX - By Stock
|
199
|
100K
|
26
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
randomvirus
|
13K |
5.6M |
3 |
18/09/20 |
| 18/09/20 |
ASX - By Stock
|
13K
|
5.6M
|
3
|
|